Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Institutional participation in digital assets reached new quarterly benchmarks as spot ETF structures provided traditional funds regulated access to crypto exposure.
Liquidity Compression
Order book depth across major spot exchanges expanded by 22%, reducing slippage for transactions exceeding $10 million and dampening retail-driven volatility.
Active pharmaceutical ingredient manufacturers invest in continuous manufacturing to resolve global GLP-1 shortages.
Contract development and manufacturing organizations expand capacity to meet unprecedented global demand.
Contract manufacturing constraints force drugmakers to invest heavily in specialized fill-finish facility construction.
Pharmaceutical manufacturers are investing billions in fill-finish capacity to meet rising demand for obesity and diabetes treatments.
Pharmaceutical developers deploy customized messenger RNA platforms to target patient-specific tumor mutations.
Pharmaceutical firms leverage historical patient data to reduce trial costs and speed regulatory submission timelines.